Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AiVita Biomedical

Latest From AiVita Biomedical

Venture Funding Deals: I-Mab Is The Mega-Round Leader With $220m Series C

Freeline Therapeutics, I-Mab Biopharma, Kaleido Biosciences and Precision BioSciences raised more than $100m each, but Chinese start-ups continue to bring in some of this year's largest venture capital mega rounds, with $220m in Series C cash to fund development of immuno-oncology and inflammatory disease drug candidates.

Financing StartUps and SMEs

Finance Watch: Dementia Discovery Fund Exceeds Fundraising Goal By $150m

Private Company Edition: The Dementia Discovery Fund started in 2015 with plans to raise $200m to fund early-stage development of disease-modifying drugs, but recently closed its fundraising with $350m in commitments. Also, Kaleido's $101m Series C is among three recent $100m-plus rounds.

Financing StartUps and SMEs

Pipeline Watch: Phase III Starts For BL-8040, Trigriluzole, MIN-101

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

AIVITA Stem Cell Skin Care; Scent Republik Fragrance Stiks For Tweens; More Cosmetics Product News

AIVITA Biomedical plans to support its clinical cancer development programs with revenue from a skin-care line featuring its proprietary stem cell technology; Scent Republik, founded by two dads as a fresh take on kid's cosmetics, launches fragrance "stiks." More news in brief.

Launches Commercial
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • AiVita Biomedical
  • Senior Management
  • Hans S Keirstead, PhD, CEO
    Robert O Dillman, MD, CMO
    Gabriel Nistor, MD, CSO
    Ed Inal, COO
  • Contact Info
  • AiVita Biomedical
    Phone: (949) 872-2555
    18301 Von Karman Ave.
    Ste. 130
    Irvine, CA 92162